4//SEC Filing
Levine Mark S. 4
Accession 0001764013-24-000085
CIK 0001764013other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:18 PM ET
Size
5.3 KB
Accession
0001764013-24-000085
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Levine Mark S.
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-04-24$28.90/sh−3,963$114,531→ 343,156 total
Footnotes (1)
- [F1]On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 8,937 of these RSUs vested on April 19, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001617236
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:18 PM ET
- Size
- 5.3 KB